DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Nitrendipine is an investigational drug.
There have been 8 clinical trials for Nitrendipine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hypertension, Coronavirus Infections, and Neoplasm Metastasis. The leading clinical trial sponsors are Haining Health-Coming Biotech Co., Ltd., West China Hospital, and Katholieke Universiteit Leuven.
Recent Clinical Trials for Nitrendipine
|Coronavirus ACE Inhibitor Investigation||National University of Ireland, Galway, Ireland||Phase 4|
|Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Treatment of Hypertension in Tibetan Adult Population||West China Hospital||Phase 4|